Xiaojing Wu

Xiaojing Wu

Auto-generated profile, based on publicly available information

Xiaojing Wu

Basic Medical School, Anhui Medical University , Hefei 230022, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
XSXiaolei Song
Xiaolei Song
XWXiaojing Wu
Xiaojing Wu
ZZZihan Zhang
Zihan Zhang
ZCZhangxiu Cui
Zhangxiu Cui
YZYong Zheng
Yong Zheng
JSJian Sun
Jian Sun
Targeting death receptor‐mediated apoptosis in T‐cell acute lymphoblastic leukemia (T‐ALL), an aggressive disease with poor prognosis, is hindered by the inherent resistance of primary leukemia cells. Knowledge on therapeutic vulnerabilities in these malignant cells will provide opportunities for developing novel combinatory treatments for patients. Using label‐free quantitative mass spectrometry and subcellular fractionation techniques, we systematically compared organelle‐specific proteomes between Jurkat cells, an in vitro model for T‐ALL, and a Jurkat mutant with increased resistance to death receptor‐mediated apoptosis. By identifying several differentially regulated protein clusters, our data argued that extensive metabolic reprograming in the mitochondria, characterized by enhanced respiration and energy production, might allow cells to evade DR5‐mediated cytotoxicity. Further analysis using clinical datasets demonstrated that the elevated expression of a three‐gene signature, consisting of SDHA, IDH3A, and ANXA11, was significantly associated with poor survival of acute leukemia patients. Our analysis therefore provided a unique dataset for a mechanistic understanding of T‐ALL and for the design of novel ALL treatments.

23 November 2023 in Bioinformatics
Verified
Journal Article
Open access
PDF file
XWXiaojing Wu
Xiaojing Wu
MHMingfei Han
Mingfei Han
XSXinyu Song
Xinyu Song
SHSong He
Song He
XBXiaochen Bo
Xiaochen Bo
YZYunping Zhu
Yunping Zhu
Summary: A variety of computational methods have been developed to identify functionally related gene modules from genome-wide gene expression profiles. Integrating the results of these methods to identify consensus modules is a promising approach to produce more accurate and robust results. In this application note, we introduce COMMO, the first web server to identify and analyze consensus gene functionally related gene modules from different module detection methods. First, COMMO implements eight state-of-the-art module detection methods and two consensus clustering algorithms. Second, COMMO provides users with mRNA and protein expression data for 33 cancer types from three public databases. Users can also upload their own data for module detection. Third, users can perform functional enrichment and two types of survival analyses on the observed gene modules. Finally, COMMO provides interactive, customizable visualizations and exportable results. With its extensive analysis and interactive capabilities, COMMO offers a user-friendly solution for conducting module-based precision medicine research. Availability and implementation: COMMO web is available at https://commo.ncpsb.org.cn/, with the source code available on GitHub: https://github.com/Song-xinyu/COMMO/tree/master.